Clinical trials in Bahamas
20 studies list at least one site in Bahamas. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2024-04-19.
Status
- Completed
- 12
- Terminated
- 3
- Status unknown
- 2
- Recruiting
- 2
- Not yet recruiting
- 1
Phase
- Phase 2
- 11
- Phase 3
- 6
- Phase 1
- 4
- Phase 4
- 1
Most studied here
Who runs them
Cellcolabs Clinical LTD. (3) · Boehringer Ingelheim (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Hoffmann-La Roche (2) · Halscion, Inc. (2) · Puma Biotechnology, Inc. (2) · Zhittya Genesis Medicine, Inc. (1) · MedImmune LLC (1)
Studies
Recruiting first, then most recently updated. Showing 20 of 20 — search for more.
- A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular EventsRecruitingNCT06087848Phase 1/2
- A Study of Human Allogeneic Bone-marrow Derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Musculoskeletal Injuries and/or DegenerationRecruitingNCT06074783Phase 1/2
- A Study of Human Allogeneic Bone-marrow-derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Aging FrailtyNot yet recruitingNCT06070532Phase 1/2
- A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)CompletedNCT01120184Phase 3
- Intranasal Human FGF-1 for Subjects With Parkinson's DiseaseStatus unknownNCT05493462Phase 1
- Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During PregnancyCompletedNCT00017719Phase 3
- A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their BabiesCompletedNCT00000942Phase 3
- Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast CancerCompletedNCT00878709Phase 3
- Tivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast CancerTerminatedNCT01745367Phase 2
- Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast CancerCompletedNCT01446159Phase 2
- A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk FactorsCompletedNCT02019264Phase 4
- Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast CancerCompletedNCT00915018Phase 2
- Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic PatientsStatus unknownNCT03562208Phase 2/3
- A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast CancerCompletedNCT00976989Phase 2
- Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLCCompletedNCT00824408Phase 2
- A Post Market Study Evaluating the Safety, Device Perfomance and Possible Emergent Risks of Celotres in Preventing Recurrence in Keloid Lesions Treated Adjunctive to Surgical ExcisionCompletedNCT01706861Not applicable
- Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PITerminatedNCT00517192Phase 3
- A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.TerminatedNCT00144105Phase 2
- A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected InfantsCompletedNCT00000873Not applicable
- Evaluation of the Initial Safety and Efficacy of Keloid Lesions Treated With MF-4181CompletedNCT01446770Phase 2